Correlation Between Veracyte and Viking Therapeutics
Can any of the company-specific risk be diversified away by investing in both Veracyte and Viking Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Viking Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Viking Therapeutics, you can compare the effects of market volatilities on Veracyte and Viking Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Viking Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Viking Therapeutics.
Diversification Opportunities for Veracyte and Viking Therapeutics
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between Veracyte and Viking is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Viking Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viking Therapeutics and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Viking Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viking Therapeutics has no effect on the direction of Veracyte i.e., Veracyte and Viking Therapeutics go up and down completely randomly.
Pair Corralation between Veracyte and Viking Therapeutics
Given the investment horizon of 90 days Veracyte is expected to generate 0.69 times more return on investment than Viking Therapeutics. However, Veracyte is 1.45 times less risky than Viking Therapeutics. It trades about 0.3 of its potential returns per unit of risk. Viking Therapeutics is currently generating about -0.35 per unit of risk. If you would invest 3,412 in Veracyte on August 28, 2024 and sell it today you would earn a total of 698.00 from holding Veracyte or generate 20.46% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Veracyte vs. Viking Therapeutics
Performance |
| Timeline |
| Veracyte |
| Viking Therapeutics |
Veracyte and Viking Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Veracyte and Viking Therapeutics
The main advantage of trading using opposite Veracyte and Viking Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Viking Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viking Therapeutics will offset losses from the drop in Viking Therapeutics' long position.| Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
| Viking Therapeutics vs. Terns Pharmaceuticals | Viking Therapeutics vs. Akero Therapeutics | Viking Therapeutics vs. Madrigal Pharmaceuticals | Viking Therapeutics vs. Sarepta Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Stocks Directory Find actively traded stocks across global markets |